Tove Kirkegaard
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Genetics top 10%
- Immunology and Allergy top 5%
- Co-authors
- John M.S. BartlettSian ToveyJean‐Marie DelaisséNiels T. FogedLiane M. McGlynnBarbara DunneCaroline WittonThomas Lenhard
- Topics
- Estrogen and related hormone effects (10 papers)HER2/EGFR in Cancer Research (8 papers)Protease and Inhibitor Mechanisms (7 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Tove Kirkegaard
30 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 828
- Oncology 583
- Cancer Research 547
- Genetics 250
- Immunology and Allergy 180
Countries citing papers authored by Tove Kirkegaard
This map shows the geographic impact of Tove Kirkegaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tove Kirkegaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tove Kirkegaard more than expected).
Fields of papers citing papers by Tove Kirkegaard
This network shows the impact of papers produced by Tove Kirkegaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tove Kirkegaard. The network helps show where Tove Kirkegaard may publish in the future.
Co-authorship network of co-authors of Tove Kirkegaard
This figure shows the co-authorship network connecting the top 25 collaborators of Tove Kirkegaard. A scholar is included among the top collaborators of Tove Kirkegaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tove Kirkegaard. Tove Kirkegaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 2 | |
| 3 | 16 | |
| 4 | 53 | |
| 5 | 21 | |
| 6 | 24 | |
| 7 | 8 | |
| 8 | 24 | |
| 9 | 70 | |
| 10 | 41 | |
| 11 | 27 | |
| 12 | 2 | |
| 13 | 224 | |
| 14 | 124 | |
| 15 | 84 | |
| 16 | 19 | |
| 17 | 7 | |
| 18 | 173 | |
| 19 | 13 | |
| 20 | 210 |
About Tove Kirkegaard
Tove Kirkegaard is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), HER2/EGFR in Cancer Research (8 papers) and Protease and Inhibitor Mechanisms (7 papers). The work is most often cited by research in Cancer Research (547 citations), Immunology and Allergy (180 citations) and Oncology (583 citations). Tove Kirkegaard has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include John M.S. Bartlett, Sian Tovey, Jean‐Marie Delaissé, Niels T. Foged, Liane M. McGlynn, Barbara Dunne, Caroline Witton, Thomas Lenhard, Alison Lyon and Timothy G. Cooke. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.